Unknown

Dataset Information

0

Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.


ABSTRACT: BACKGROUND:Osteonecrosis is a common toxicity associated with glucocorticoid (e.g., dexamethasone and prednisone) treatment of children with acute lymphoblastic leukemia (ALL), but risk factors are incompletely defined. Infections are also a common complication of ALL therapy. Lipopolysaccharide (LPS) is used experimentally to mimic infection-related systemic effects. To our knowledge, the contribution of systemic infections to the risk of glucocorticoid-induced osteonecrosis has not been investigated. PROCEDURE:Patients with ALL on St. Jude Total Therapy XV (n = 365) were assessed for documented bacteremia prior to development of osteonecrosis, which was confirmed by MRI, and graded using the National Cancer Institute's Common Terminology for Adverse Events (version 3.0). In a preclinical model, Balb/cJ mice treated with dexamethasone plus or minus LPS were assessed for frequency and severity of osteonecrosis and arteriopathy. RESULTS:We found that patients with ALL who experienced bacteremia had a higher frequency of symptomatic osteonecrosis (?grade 2) than those who did not (OR: 1.88; 95% CI, 1.03-3.41, P = 0.038). LPS exacerbated experimental dexamethasone-induced osteonecrosis. Mice treated with dexamethasone plus LPS had a higher incidence of osteonecrosis (P = 0.00086) and arteriopathy (P = 0.0047) than did those treated with dexamethasone alone, and the severity of osteonecrosis (P = 0.00045) and arteriopathy (P = 0.0048) was also more pronounced with the addition of LPS treatment. The increase in osteonecrosis was not explained by any alteration of dexamethasone pharmacokinetics by LPS. CONCLUSIONS:These data identify systemic infection during ALL therapy as a novel risk factor in the development of glucocorticoid-induced osteonecrosis.

SUBMITTER: Finch ER 

PROVIDER: S-EPMC6472979 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.

Finch Emily R ER   Janke Laura J LJ   Smith Colton A CA   Karol Seth E SE   Pei Deqing D   Cheng Cheng C   Kaste Sue C SC   Inaba Hiroto H   Pui Ching-Hon CH   Wolf Joshua J   Relling Mary V MV  

Pediatric blood & cancer 20190213 6


<h4>Background</h4>Osteonecrosis is a common toxicity associated with glucocorticoid (e.g., dexamethasone and prednisone) treatment of children with acute lymphoblastic leukemia (ALL), but risk factors are incompletely defined. Infections are also a common complication of ALL therapy. Lipopolysaccharide (LPS) is used experimentally to mimic infection-related systemic effects. To our knowledge, the contribution of systemic infections to the risk of glucocorticoid-induced osteonecrosis has not bee  ...[more]

Similar Datasets

| S-EPMC8506634 | biostudies-literature
| S-EPMC4788417 | biostudies-literature
| S-EPMC2889316 | biostudies-other
| S-EPMC6209217 | biostudies-literature
| S-EPMC7435053 | biostudies-literature
| S-EPMC2699052 | biostudies-literature
| S-EPMC8734283 | biostudies-literature
| S-EPMC6990927 | biostudies-literature
| S-EPMC8422618 | biostudies-literature
| S-EPMC6916262 | biostudies-literature